000 | 01534 a2200517 4500 | ||
---|---|---|---|
005 | 20250515221611.0 | ||
264 | 0 | _c20100514 | |
008 | 201005s 0 0 fre d | ||
022 | _a0370-629X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFreres, P | |
245 | 0 | 0 |
_a["Triple negative" breast cancer]. _h[electronic resource] |
260 |
_bRevue medicale de Liege _cMar 2010 |
||
300 |
_a120-6 p. _bdigital |
||
500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xchemistry |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMastectomy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 |
_aReceptors, Progesterone _xanalysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCollignon, J | |
700 | 1 | _aGennigens, C | |
700 | 1 | _aScagnol, I | |
700 | 1 | _aRorive, A | |
700 | 1 | _aBarbeaux, A | |
700 | 1 | _aCoucke, P A | |
700 | 1 | _aJérusalem, G | |
773 | 0 |
_tRevue medicale de Liege _gvol. 65 _gno. 3 _gp. 120-6 |
|
999 |
_c19769450 _d19769450 |